GRObio is funded by a premier syndicate of biotech investors who share the Company’s bold vision to redefine protein therapeutics with an expanded amino acid alphabet.
Our lead investors bring a wealth of experience in biotechnology, computation, therapeutic development, and commercialization.
![](https://grobiosciences.wpenginepowered.com/wp-content/uploads/2024/02/Investors-Image.png)
![](https://grobiosciences.wpenginepowered.com/wp-content/uploads/2024/02/Leaps-1.png)
![](https://grobiosciences.wpenginepowered.com/wp-content/uploads/2024/02/redmile.png)
![](https://grobiosciences.wpenginepowered.com/wp-content/uploads/2024/02/digitalis-ventures-1.png)
![](https://grobiosciences.wpenginepowered.com/wp-content/uploads/2024/02/innovation-endeavors-1.png)
![](https://grobiosciences.wpenginepowered.com/wp-content/uploads/2024/03/Pillar.png)
![](https://grobiosciences.wpenginepowered.com/wp-content/uploads/2024/03/Rising-Tide.png)